(b)
| Time, h | RB | RBCUR | RBHYD | RBAA | RBARG | RBLA | RBKA | MUL | CTRL |
|---|---|---|---|---|---|---|---|---|---|
| (i) The percentage of wound closure of NIH 3T3 cell treated with 5% RB maltodextrin (DE 10–14) with 100 ppm of various additives | |||||||||
| 0 | 0.00 ± 0.00a A | ||||||||
| 3 | 3.54 ± 0.76a A | 2.51 ± 3.45a AB | 6.94 ± 3.51a AB | 7.39 ± 1.21a AB | 5.01 ± 0.60a AB | 7.27 ± 1.53ab B | 3.64 ± 2.49a AB | 2.04 ± 0.60a A | 12.04 ± 0.53b D |
| 6 | 12.96 ± 4.06ab AB | 7.71 ± 1.06a A | 13.87 ± 3.85ab ABC | 14.43 ± 4.04ab AB | 11.22 ± 4.21ab AB | 20.64 ± 5.11b BC | 10.75 ± 3.00ab AB | 6.89 ± 3.19b A | 21.17 ± 1.72b BC |
| 9 | 24.41 ± 5.17bc BC | 21.68 ± 3.48b ABC | 20.65 ± 5.77bc AB | 20.62 ± 2.46bc AB | 23.05 ± 7.83bc ABC | 32.27 ± 7.10c C | 19.58 ± 2.64bc AB | 8.42 ± 2.17cd A | 29.93 ± 4.63d DE |
| 12 | 33.50 ± 8.81c AB | 28.14 ± 1.33b A | 27.90 ± 8.70c A | 26.80 ± 6.94c A | 28.86 ± 9.24c A | 44.19 ± 4.17d AB | 27.90 ± 9.47c A | 10.20 ± 0.57d A | 36.86 ± 1.47c B |
| 24 | 57.91 ± 5.67d B | 55.56 ± 10.34c B | 53.71 ± 2.41d B | 48.97 ± 6.62d B | 47.90 ± 3.76d B | 46.51 ± 4.05d B | 45.58 ± 8.33d B | 10.71 ± 1.73d A | 100.00 ± 0.00d A |
|
| |||||||||
| (ii) The percentage of wound closure of NIH 3T3 cell treated with 10% RB maltodextrin (DE 10–14) with 100 ppm of various additives | |||||||||
| 3 | 19.23 ± 1.65b C | 15.79 ± 0.00a B | 16.40 ± 0.17b C | 14.81 ± 1.44b BC | 16.33 ± 1.79b E | 17.74 ± 0.00b C | 12.10 ± 0.62b A | 0.00 ± 0.00a A | |
| 6 | 32.69 ± 0.70b A | 29.82 ± 2.11b BC | 28.95 ± 4.96c BC | 23.33 ± 6.06c BC | 31.78 ± 0.92c C | 28.09 ± 0.75c AB | 21.66 ± 0.00c A | ||
| 9 | 48.73 ± 2.32c BC | 42.11 ± 6.88b CD | 36.36 ± 4.73d DE | 30.23 ± 1.52c CD | 38.32 ± 0.78d E | 34.83 ± 0.00c AB | 29.26 ± 0.31d A | ||
| 12 | 61.13 ± 1.39d D | 52.97 ± 3.68c D | 51.52 ± 2.72e C | 47.78 ± 1.90d C | 47.66 ± 0.75d C | 44.94 ± 4.49d B | 32.98 ± 0.56e A | ||
| 24 | 100.00 ± 0.00e A | 100.00 ± 0.00d A | 100.00 ± 0.00f A | 100.00 ± 0.00e A | 100.00 ± 0.00e A | 100.00 ± 0.00e A | 100.00 ± 0.00f A | ||
|
| |||||||||
| (iii) The percentage of wound closure of NIH 3T3 cell treated with 20% RB maltodextrin (DE 10–14) with 100 ppm of various additives | |||||||||
| 3 | 7.27 ± 0.00b AB | 11.24 ± 3.08ab A | 11.11 ± 0.00ab A | 10.61 ± 4.77a AB | 12.16 ± 2.66b C | 6.93 ± 1.75a A | 5.32 ± 4.22b A | 0.00 ± 0.00a A | |
| 6 | 15.64 ± 3.88c AB | 16.43 ± 0.00abc B | 16.87 ± 3.18abc AB | 22.07 ± 1.92a AB | 18.11 ± 0.24b B | 20.50 ± 7.62b B | 4.98 ± 2.81b A | ||
| 9 | 20.73 ± 1.47d AB | 20.75 ± 0.00bc B | 23.46 ± 8.67bc AB | 27.37 ± 2.97AB | 22.43 ± 4.92b AB | 24.65 ± 4.94bc B | 11.63 ± 3.52b A | ||
| 12 | 22.18 ± 0.84d A | 27.38 ± 3.97c A | 29.22 ± 9.62c A | 33.80 ± 0.00b A | 30.54 ± 3.48c A | 36.01 ± 1.77cd A | 25.58 ± 2.42c A | ||
| 24 | 72.73 ± 1.69e C | 67.44 ± 0.90d C | 66.26 ± 1.78d C | 49.16 ± 3.76c B | 44.59 ± 4.81d AB | 43.77 ± 3.35d AB | 34.55 ± 2.32d A | ||